Latest filing published 10 Jul 2026 for 프레스티지바이오로직스. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of 프레스티지바이오파마 in 프레스티지바이오로직스. In total, 34 filings cover trades dated from 18 March 2021 to 10 July 2026.
Every open-market trade on record is a purchase: 34 purchases, and no sale. No amount is published for 34 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.
None of the 34 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 10 July 2026 came the latest disclosure, an open-market purchase in 프레스티지바이오로직스. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations